One of Valeant's top shareholders on Tuesday threw his support behind its proposed takeover bid for Botox-maker Allergan.
McDonald's reported a lower quarterly profit as sales at the fast-food chain's established U.S. restaurants fell more than expected.
U.S. home resales fell to their lowest level in more than 1-1/2 years in March, amid signs a recent downward trend may be nearing an end.
Industry-watchers believe that rather than closing the book on Nokia, sealing the $7.5 billion deal could give it a new lease of life.
The strong performance of the so-called "fragile five" currencies has marked a return to favor for the so-called carry trade.
With capital flooding out of the country, the stock market falling, the Crimea seizure is turning out to be a costly move.
Vice President Joe Biden told Ukrainian presidential candidates and Parliament that the U.S. was ready to help Ukraine and they must fight corruption.
Male doctors on average make 88 percent more in Medicare reimbursements than female physicians, according to an analysis of government data.
A form of powdered alcohol quickly became the subject of online controversy, and its maker immediately withdrew its license application.
As Italy's new government promises much-needed reforms to invigorate the country's economy, experts have flagged one area in dire need of change.
As markets head for the summer doldrums, analysts are becoming concerned that the long bull market is ripe for a correction.
Dennis Gartman is back to buying stocks and is "pleasantly long" on the market after bailing out in early April.
After an early April swoon, most stocks have recovered. However, there are still 8 of them that are down 10 percent or more. Investors are suffering.
A new type of ETF portfolio is being embraced by the affluent, but investors would be wise to watch for red flags with so-called ETFs of ETFs.
Caterpillar CEO Doug Oberhelman's pay fell 33 percent last year because of the company's failure to meet promised profit and performance targets.
Valeant Pharmaceuticals and Bill Ackman are proposing a cash-and-stock deal for Allergan that could be worth about $45 billion.
Five generations after it was founded, Leinenkugel Brewing is still run by the family and still trying to help those who just can't pronounce the name.
Pharmaceutical industry observers have been waiting for a rush of deals for months - and they might have finally arrived.
The Lefty mayors of NY and LA talk about income equality but when it comes to Hollywood and taxes, they're starry-eyed, says Jake Novak.
Ford Motors is expected to name Mark Fields as successor to CEO Alan Mulally, sources told CNBC.